[
  {
    "ts": null,
    "headline": "Dow Jones Leader Amgen Leads These Biotech Stocks Heading Into Q4 Earnings Season",
    "summary": "Dow Jones biotech giant Amgen, along with fellow biotech stocks Gilead and Vertex, are due to report fourth-quarter earnings results soon.",
    "url": "https://finnhub.io/api/news?id=5c33e62ec9ac46c3e7a93a34534126ef0117bed0a6cd4d9b53bde2d7c0defdab",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1769789655,
      "headline": "Dow Jones Leader Amgen Leads These Biotech Stocks Heading Into Q4 Earnings Season",
      "id": 138307366,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "GILD",
      "source": "Yahoo",
      "summary": "Dow Jones biotech giant Amgen, along with fellow biotech stocks Gilead and Vertex, are due to report fourth-quarter earnings results soon.",
      "url": "https://finnhub.io/api/news?id=5c33e62ec9ac46c3e7a93a34534126ef0117bed0a6cd4d9b53bde2d7c0defdab"
    }
  },
  {
    "ts": null,
    "headline": "H.C. Wainwright Remains a Buy on Nurix Therapeutics (NRIX)",
    "summary": "​Nurix Therapeutics, Inc. (NASDAQ:NRIX) is one of the Best Small Cap Stocks Ready to Explode in 2026. On January 21, Robert Burns from H.C. Wainwright reiterated a Buy rating on the stock with a $31 price target. Earlier, on January 14, BTIG reiterated a Buy rating on the stock with a $30 price target. Analysts […]",
    "url": "https://finnhub.io/api/news?id=f69b363a3f92befcdf49eada0c552ab9b1bb4399ef55a4ea336ef902b158eca0",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1769784436,
      "headline": "H.C. Wainwright Remains a Buy on Nurix Therapeutics (NRIX)",
      "id": 138306213,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "GILD",
      "source": "Yahoo",
      "summary": "​Nurix Therapeutics, Inc. (NASDAQ:NRIX) is one of the Best Small Cap Stocks Ready to Explode in 2026. On January 21, Robert Burns from H.C. Wainwright reiterated a Buy rating on the stock with a $31 price target. Earlier, on January 14, BTIG reiterated a Buy rating on the stock with a $30 price target. Analysts […]",
      "url": "https://finnhub.io/api/news?id=f69b363a3f92befcdf49eada0c552ab9b1bb4399ef55a4ea336ef902b158eca0"
    }
  },
  {
    "ts": null,
    "headline": "3 Cash-Producing Stocks with Warning Signs",
    "summary": "While strong cash flow is a key indicator of stability, it doesn’t always translate to superior returns. Some cash-heavy businesses struggle with inefficient spending, slowing demand, or weak competitive positioning.",
    "url": "https://finnhub.io/api/news?id=cf39d79673ad626e296c732d51013eb2162b961320c09ef35ce18416ad9f387c",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1769747842,
      "headline": "3 Cash-Producing Stocks with Warning Signs",
      "id": 138309055,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "GILD",
      "source": "Yahoo",
      "summary": "While strong cash flow is a key indicator of stability, it doesn’t always translate to superior returns. Some cash-heavy businesses struggle with inefficient spending, slowing demand, or weak competitive positioning.",
      "url": "https://finnhub.io/api/news?id=cf39d79673ad626e296c732d51013eb2162b961320c09ef35ce18416ad9f387c"
    }
  }
]